Condition: Acute Respiratory Distress Syndrome (ARDS) · ARDS · ARDS (Acute Respiratory Distress Syndrome) · Sponsor: PPD Development, LP
This is a Phase 2 multicenter, randomized, double-blinded, placebo-controlled study that will evaluate the safety and efficacy of host-directed therapeutics in hospitalized adults diagnosed with Acute Respiratory Distress Syndrome (ARDS) utilizing a platform trial design. Cohort A: Participants will be randomized to receive either a placebo or vilobelimab. This record describes the default procedures and analyses for Cohort A. Please see NCT06703073 for information on the BP-ARDS-P2-001 Master Protocol.
This description comes directly from the study's public registry record.
Just Breathe Trial Team · Please email · crgjustbreathealerts.sm@thermofisher.com
Always discuss trial participation with your own doctor first.
| University of Alabama Hospital | Birmingham, Alabama, United States | Not Yet Recruiting |
| Community Regional Medical Center | Fresno, California, United States | Recruiting |
| Long Beach Memorial Medical Center | Long Beach, California, United States | Recruiting |
| University of California Irvine Medical Center | Orange, California, United States | Recruiting |
| University of California Davis Medical Center - Pulmonary Medicine | Sacramento, California, United States | Recruiting |
| Denver Health Hospital and Authority | Denver, Colorado, United States | Recruiting |
| MedStar Washington Hospital Center | Washington D.C., District of Columbia, United States | Recruiting |
| Nova Clinical Research | Bradenton, Florida, United States | Recruiting |
| North Florida / South Georgia Veterans Health System | Gainesville, Florida, United States | Recruiting |
| Sarasota Memorial Hospital | Sarasota, Florida, United States | Recruiting |
| St. Luke's Boise Medical Center | Boise, Idaho, United States | Recruiting |
| Northshore University Healthsystem Research Institute | Evanston, Illinois, United States | Not Yet Recruiting |
+ 28 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06701682